AcelRx Pharmaceuticals’ $32.5 Million Acquisition of Lowell Therapeutics

Burns & Levinson LLP represented Lowell Therapeutics, Inc. in its sale to AcelRx Pharmaceuticals. AcelRx Pharmaceuticals (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now